However, in previous clinical trials of anti-VEGF therapy for RVO, patients with any evidence of diabetic retinopathy on examination were excluded [45–47]; consequently, the association between RVO and diabetic retinopathy remained unknown. Here, VEGFA is linked to diabetic retinopathy.